| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 43.1866 | 18 |
| GSM780708 | Untreated after 4 days (C2_1) | 47.274 | 38 |
| GSM780709 | Untreated after 4 days (C3_1) | 47.1273 | 37 |
| GSM780719 | Untreated after 4 days (C1_2) | 45.6949 | 31 |
| GSM780720 | Untreated after 4 days (C2_2) | 39.8795 | 6 |
| GSM780721 | Untreated after 4 days (C3_2) | 40.2356 | 7 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 40.5381 | 8 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 45.1282 | 28 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 46.1633 | 33 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 46.0394 | 32 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 47.4945 | 39 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 43.8602 | 21 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 39.2435 | 5 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 41.3098 | 10 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 46.2545 | 33 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 44.0423 | 22 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 39.1524 | 4 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 41.5969 | 12 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 43.0541 | 18 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 45.7895 | 31 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 43.2955 | 19 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 45.5621 | 30 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 40.5585 | 8 |